Regeneron Pharmaceuticals
REGN
#117
Rank
A$191.08 B
Marketcap
$1,733
Share price
0.20%
Change (1 day)
35.36%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$11.82 B

According to Regeneron Pharmaceuticals's latest financial reports the company's total liabilities are A$11.82 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regeneron Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$10.43 B8.37%
2022-12-31A$9.62 B5%
2021-12-31A$9.16 B15.09%
2020-12-31A$7.96 B50.71%
2019-12-31A$5.28 B25.11%
2018-12-31A$4.22 B25.88%
2017-12-31A$3.35 B-4.16%
2016-12-31A$3.50 B30.52%
2015-12-31A$2.68 B70.89%
2014-12-31A$1.57 B40.18%
2013-12-31A$1.11 B39.05%
2012-12-31A$0.80 B-1.43%
2011-12-31A$0.81 B47.31%
2010-12-31A$0.55 B44.04%
2009-12-31A$0.38 B-12.13%
2008-12-31A$0.43 B-19.54%
2007-12-31A$0.54 B16.54%
2006-12-31A$0.46 B10.5%
2005-12-31A$0.42 B12.65%
2004-12-31A$0.37 B-18.37%
2003-12-31A$0.45 B5.52%
2002-12-31A$0.43 B-2.87%
2001-12-31A$0.44 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$127.46 B 978.31%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.01 B-49.08%๐Ÿ‡บ๐Ÿ‡ธ USA
A$16.37 B 38.50%๐Ÿ‡บ๐Ÿ‡ธ USA
A$164.31 B 1,290.05%๐Ÿ‡บ๐Ÿ‡ธ USA
A$83.39 B 605.53%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$91.25 B 672.03%๐Ÿ‡ซ๐Ÿ‡ท France